{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T17:25:06Z","timestamp":1772990706821,"version":"3.50.1"},"reference-count":93,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2055,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1582-4934.2010.01011.x","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T23:34:03Z","timestamp":1263598443000},"page":"555-571","source":"Crossref","is-referenced-by-count":57,"title":["Early defect of transforming growth factor \u03b21 formation in Huntington\u2019s disease"],"prefix":"10.1111","volume":"15","author":[{"given":"Giuseppe","family":"Battaglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Cannella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Riozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Orobello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion L.","family":"Maat-Schieman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Aronica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla Letizia","family":"Busceti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ciarmiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Sassone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Sipione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Frati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"Squitieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,1,15]]},"reference":[{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/8.5.813","article-title":"Formation of polyglutamine inclusions in non-CNS tissue","volume":"8","author":"Sathasivam","year":"1999","journal-title":"Hum Mol Genet."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","journal-title":"Cell."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","article-title":"Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington\u2019s disease","volume":"47","author":"de la Monte","year":"1988","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington\u2019s disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cell.2004.06.022","article-title":"Huntington\u2019s disease: new paths to pathogenesis","volume":"118","author":"Ross","year":"2004","journal-title":"Cell."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington\u2019s disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"9822","DOI":"10.1523\/JNEUROSCI.18-23-09822.1998","article-title":"Glial cell line-derived neurotrophic factor requires transforming growth factor-beta for exerting its full neurotrophic potential on peripheral and CNS neurons","volume":"18","author":"Krieglstein","year":"1998","journal-title":"J Neurosci."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.1523\/JNEUROSCI.18-23-09594.1998","article-title":"Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta","volume":"18","author":"Bruno","year":"1998","journal-title":"J Neurosci."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/jnr.21072","article-title":"Ectopic expression of phospho-Smad2 in Alzheimer\u2019s disease: uncoupling of the transforming growth factor-beta pathway","volume":"84","author":"Lee","year":"2006","journal-title":"J Neurosci Res."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1172\/JCI27341","article-title":"Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer\u2019s pathology","volume":"116","author":"Tesseur","year":"2006","journal-title":"J Clin Invest."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1111\/j.1460-9568.2006.05109.x","article-title":"Altered subcellular location of phosphorylated Smads in Alzheimer\u2019s disease","volume":"24","author":"Ueberham","year":"2006","journal-title":"Eur J Neurosci."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/nen.0b013e3180303b93","article-title":"Neurofibrillary tangles may interfere with Smad 2\/3 signaling in neurons","volume":"66","author":"Chalmers","year":"2007","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2174\/156720506779025297","article-title":"A role for TGF-beta signaling in neurodegeneration: evidence from genetically engineered models","volume":"3","author":"Tesseur","year":"2006","journal-title":"Curr Alzheimer Res."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0896-6273(03)00766-9","article-title":"Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain","volume":"40","author":"Brionne","year":"2003","journal-title":"Neuron."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1210\/en.2004-0973","article-title":"Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death","volume":"145","author":"Sortino","year":"2004","journal-title":"Endocrinology."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1471-4159.2001.00435.x","article-title":"Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways","volume":"78","author":"D\u2019Onofrio","year":"2001","journal-title":"J Neurochem."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"8297","DOI":"10.1523\/JNEUROSCI.1889-07.2007","article-title":"The use of knockout mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration\/neuroprotection","volume":"27","author":"Corti","year":"2007","journal-title":"J Neurosci."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/brain\/awg077","article-title":"Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course","volume":"126","author":"Squitieri","year":"2003","journal-title":"Brain."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","article-title":"A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length","volume":"65","author":"Langbehn","year":"2004","journal-title":"Clin Genet."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"The Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Huntington Study Group","volume":"11","author":"Huntington Study Group","year":"1996","journal-title":"Mov Disord."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"2","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB27|cit27","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease","volume":"47","author":"Ciarmiello","year":"2006","journal-title":"J Nucl Med."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","article-title":"Factors associated with slow progression in Huntington\u2019s disease","volume":"48","author":"Myers","year":"1991","journal-title":"Arch Neurol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1212\/WNL.54.2.452","article-title":"Rate of functional decline in Huntington\u2019s disease. Huntington Study Group","volume":"54","author":"Marder","year":"2000","journal-title":"Neurology."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1468-1331.2006.01264.x","article-title":"The search for cerebral biomarkers of Huntington\u2019s disease: a review of genetic models of age at onset prediction. [Review]","volume":"13","author":"Squitieri","year":"2006","journal-title":"Eur J Neurol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajmg.b.30501","article-title":"Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington\u2019s disease patients","volume":"144B","author":"Ciammola","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1359-6101(99)00037-4","article-title":"TGF-beta in blood: a complex problem","volume":"11","author":"Grainger","year":"2000","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum Mol Genet."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1096\/fj.02-0143fje","article-title":"Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus","volume":"16","author":"Katoh-Semba","year":"2002","journal-title":"FASEB J."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00259-007-0615-y","article-title":"Neuroprotective effects of riluzole in Huntington\u2019s disease","volume":"35","author":"Squitieri","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1083\/jcb.108.2.653","article-title":"Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes","volume":"108","author":"Flanders","year":"1989","journal-title":"J Cell Biol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00005072-199902000-00007","article-title":"Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures","volume":"58","author":"De Groot","year":"1999","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s004010000296","article-title":"Expression of brain-derived neurotrophic factor and tyrosine kinase B receptor proteins in glioneuronal tumors from patients with intractable epilepsy: colocalization with N-methyl-D-aspartic acid receptor","volume":"101","author":"Aronica","year":"2001","journal-title":"Acta Neuropatho."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB40|cit40","first-page":"46","volume-title":"Methods in toxicology. In vitro biological system","author":"Rose","year":"1992"},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum Mol Genet."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1750-3639.2006.00040.x","article-title":"Neuronal intranuclear and neuropil inclusions for pathological assessment of Huntington\u2019s disease","volume":"17","author":"Maat-Schieman","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat Genet."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"12748","DOI":"10.1523\/JNEUROSCI.3873-06.2006","article-title":"Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism","volume":"26","author":"del Toro","year":"2006","journal-title":"J Neurosci."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1089\/10430349950016393","article-title":"Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington\u2019s disease, as demonstrated by adenoviral gene transfer","volume":"10","author":"Bemelmans","year":"1999","journal-title":"Hum Gene Ther."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1460-9568.1999.00433.x","article-title":"Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo","volume":"11","author":"P\u00e9rez-Navarro","year":"1999","journal-title":"Eur J Neurosci."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","article-title":"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice","volume":"100","author":"Duan","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ymthe.2004.02.016","article-title":"AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease","volume":"9","author":"Kells","year":"2004","journal-title":"Mol Ther."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI27607","article-title":"Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase","volume":"116","author":"Borrell-Pag\u00e8s","year":"2006","journal-title":"J Clin Invest."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-4886(03)00044-X","article-title":"Structural and functional neuroprotection in a rat model of Huntington\u2019s disease by viral gene transfer of GDNF","volume":"181","author":"McBride","year":"2003","journal-title":"Exp Neurol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.0508875103","article-title":"Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington\u2019s disease","volume":"103","author":"McBride","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","article-title":"Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington\u2019s disease","volume":"27","author":"Lynch","year":"2007","journal-title":"J Neurosci."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/sj.gt.3302847","article-title":"Neuroprotection by GDNF-secreting stem cells in a Huntington\u2019s disease model: optical neuroimage tracking of brain-grafted cells","volume":"14","author":"Pineda","year":"2007","journal-title":"Gene Ther."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nbd.2008.02.010","article-title":"Beneficial effects of rolipram in the R6\/2 mouse model of Huntington\u2019s disease","volume":"30","author":"DeMarch","year":"2008","journal-title":"Neurobiol Disease."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington\u2019s disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J Neurochem."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2008.04.012","article-title":"Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington\u2019s disease: restoration by the neuroprotective compound CEP-1347","volume":"39","author":"Conforti","year":"2008","journal-title":"Mol Cell Neurosci."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","article-title":"Brain-derived neurotrophic factor in Huntington disease","volume":"866","author":"Ferrer","year":"2000","journal-title":"Brain Res."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington\u2019s disease and rescue by BDNF delivery","volume":"52","author":"Zuccato","year":"2005","journal-title":"Pharmacol Res."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington\u2019s disease","volume":"18","author":"Zuccato","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.nbd.2006.10.005","article-title":"GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action","volume":"25","author":"Schober","year":"2007","journal-title":"Neurobiol Dis."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/jnr.1229","article-title":"Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex","volume":"66","author":"Sometani","year":"2001","journal-title":"J Neurosci Res."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1242\/dev.01893","article-title":"SMAD pathway mediation of BDNF and TGF beta 2 regulation of proliferation and differentiation of hippocampal granule neurons","volume":"132","author":"Lu","year":"2005","journal-title":"Development."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/122.9.1667","article-title":"Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington\u2019s disease","volume":"122","author":"Harris","year":"1999","journal-title":"Brain."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington\u2019s disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J Exp Med."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington\u2019s disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00702-009-0328-4","article-title":"Abnormal morphology of peripheral cell tissues from patients with Huntington disease","volume":"117","author":"Squitieri","year":"2010","journal-title":"J Neural Transm."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/359693a0","article-title":"Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease","volume":"359","author":"Shull","year":"1992","journal-title":"Nature."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","article-title":"Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease","volume":"14","author":"Van Raamsdonk","year":"2005","journal-title":"Hum Mol Genet."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington\u2019s disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"J Neurosci."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB167|cit74","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0028-3908(99)00092-1","article-title":"Pharmacological agents acting at subtypes of metabotropic glutamate receptors","volume":"38","author":"Schoepp","year":"1999","journal-title":"Neuropharmacology."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(01)02098-5","article-title":"Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes","volume":"310","author":"Mizuta","year":"2001","journal-title":"Neurosci Lett."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0306-4522(00)00084-1","article-title":"Transforming growth factor-beta 2 is anterogradely and retrogradely transported in motoneurons and up-regulated after nerve injury","volume":"97","author":"Jiang","year":"2000","journal-title":"Neuroscience."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/156720506777632916","article-title":"Tgf-Beta pathway as a potential target in neurodegeneraation and Alzheimer\u2019s","volume":"3","author":"Wyss-Coray","year":"2006","journal-title":"Curr Alzh Res."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cytogfr.2005.09.011","article-title":"Transforming growth factor-\u03b2 signalling in brain disorder","volume":"17","author":"Vivien","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0896-6273(03)00766-9","article-title":"Loss of TGF-\u03b21 leads to increate neuronal cell death and microgliosis in mouse brain","volume":"40","author":"Brionne","year":"2003","journal-title":"Neuron."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0197-0186(00)00084-X","article-title":"TGF-beta1 inhibits caspase 3 activation and neuronal apoptosis in rat hippocampal cultures","volume":"38","author":"Zhu","year":"2001","journal-title":"Neurochem Int."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0026-895X(25)08714-0","article-title":"Protective effect of transforming growth factor-beta1 on beta-amyloid neurotoxicity in rat hippocampal neurons","volume":"49","author":"Prehn","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1523\/JNEUROSCI.22-10-03898.2002","article-title":"Transforming growth factor-beta1 increases Bad phosphorylation and protects neurons against damage","volume":"22","author":"Zhu","year":"2002","journal-title":"J Neurosci."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.neuroscience.2003.10.037","article-title":"Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase\/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase 1,2 signaling pathways","volume":"123","author":"Zhu","year":"2004","journal-title":"Neuroscience."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1073\/pnas.92.12.5545","article-title":"Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism","volume":"92","author":"Datto","year":"1995","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/(SICI)1097-4652(199609)168:3<510::AID-JCP3>3.0.CO;2-S","article-title":"Differential regulation of p27 and cyclin D1 by TGF-beta and EGF in C3H 10T1\/2 mouse fibroblasts","volume":"168","author":"Ravitz","year":"1996","journal-title":"J Cell Physiol."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0896-6273(94)90276-3","article-title":"Analysis of cell-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death","volume":"12","author":"Freeman","year":"1994","journal-title":"Neuron."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1242\/dev.121.8.2385","article-title":"The induction of multiple cell cycle events precedes target-related neuronal death","volume":"121","author":"Herrup","year":"1995","journal-title":"Development."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-2236(00)01663-5","article-title":"Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path","volume":"24","author":"Copani","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1073\/pnas.1532244100","article-title":"Increased cell proliferation and neurogenesis in the adult human Huntington\u2019s disease brain","volume":"100","author":"Curtis","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1074\/jbc.M707730200","article-title":"Differential involvement of cell cycle reactivation between striatal and cortical neurons in cell death induced by 3-nitropropionic acid","volume":"283","author":"Akashiba","year":"2008","journal-title":"J Biol Chem."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0896-6273(93)90192-T","article-title":"Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids","volume":"11","author":"Yamagata","year":"1993","journal-title":"Neuron."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1471-4159.1996.66010006.x","article-title":"Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation","volume":"66","author":"Adams","year":"1996","journal-title":"J Neurochem."},{"key":"10.1111\/j.1582-4934.2010.01011.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/exnr.1997.6429","article-title":"Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer\u2019s disease","volume":"144","author":"Tocco","year":"1997","journal-title":"Exp Neurol."}],"container-title":["Journal of Cellular and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1582-4934.2010.01011.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1582-4934.2010.01011.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T20:09:46Z","timestamp":1739736586000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1582-4934.2010.01011.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,15]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01011.x","relation":{},"ISSN":["1582-1838"],"issn-type":[{"value":"1582-1838","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1,15]]}}}